Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > New York Times artilce
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by calgueston Aug 08, 2019 11:32am
86 Views
Post# 30006961

RE:RE:RE:New York Times artilce

RE:RE:RE:New York Times artilceAlthough the comments page was closed there is a place to respond to the artical via email.I sent them a note saying there is a solution the VP4 made by TSO3 who were given FDA approval in May 2018. Think every share holder should do the same.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities